Ticker Details
Fortrea Holdings Inc. Common Stock
IPO Date:	July 3, 2023
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.02B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.48 | 2.77%
Avg Daily Range (30 D):	$0.60 | 4.19%
Avg Daily Range (90 D):	$0.48 | 3.66%

Institutional Daily Volume
Avg Daily Volume:	1.33M
Avg Daily Volume (30 D):	1.44M
Avg Daily Volume (90 D):	1.16M

Trade Size
Avg Trade Size (Sh.):	79
Avg Trade Size (Sh.) (30 D):	69
Avg Trade Size (Sh.) (90 D):	64

Institutional Trades
Total Institutional Trades:	1,926
Avg Institutional Trade:	$2.51M
Avg Institutional Trade (30 D):	$2.19M
Avg Institutional Trade (90 D):	$2.26M
Avg Institutional Trade Volume:	.14M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$4.07M
Avg Closing Trade (30 D):	$3.08M
Avg Closing Trade (90 D):	$3.12M
Avg Closing Volume:	247.01K

News

Dec 12, 2025 @ 7:37 PM Notice to Long-Term Shareholders of Cytokinetics, ... Source: Grabar Law Office

Dec 10, 2025 @ 11:00 PM Fortrea Announces Grant of Inducement Awards Under... Source: Fortrea

Dec 2, 2025 @ 5:39 PM Important Notice to Long-Term Shareholders of Cyto... Source: Joshua H. Grabar

Nov 24, 2025 @ 12:00 PM Fortrea Completes $75.7 Million Senior Notes Tende... Source: Fortrea

Nov 15, 2025 @ 1:22 PM Important Notice to Long-Term Shareholders of Avan... Source: Grabar Law Office

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$-.17	$-4.14	$-6.25
Diluted EPS	$-.17	$-4.14	$-6.25
Revenue	$701.3M	$710.3M	$651.3M
Gross Profit
Net Income / Loss	$-15.9M	$-374.9M	$-562.9M
Operating Income / Loss	$-8.6M	$-330.3M	$-520.1M
Cost of Revenue
Net Cash Flow	$50.1M	$-20.4M	$-16.9M
PE Ratio